Open-source antibodies as a path to enhanced research reproducibility and transparency

Area of Science:

• Biomedical Research
• Immunology
• Reagent Development

Background:

• Antibodies are essential research tools, but their accessibility and characterization pose challenges to transparency and reproducibility.
• Lack of standardized, open access to reliable antibody sources hinders scientific progress.

Purpose of the Study:

• To introduce and advocate for the adoption of open-source antibodies in biomedical research.
• To establish a framework for open-source antibody development and distribution.
• To enhance research transparency, reproducibility, and cost-effectiveness.

Main Methods:

• Defining the core tenets of open-source antibodies: ready availability, renewable sources (hybridoma, plasmid), and public sequence data.
• Establishing a consortium (UC Davis/NIH NeuroMab Facility, DSHB, Addgene) to provide open-source antibody access.
• Encouraging community participation in utilizing and contributing to open-source antibody resources.

Main Results:

• A consortium has been formed to offer a substantial collection of well-characterized open-source antibodies.
• The open-source model promises to increase the reliability and reduce the cost of antibody-based research.
• Potential for generating antibody variants tailored to specific research needs through sequence accessibility.

Conclusions:

• Open-source antibodies offer a paradigm shift for biomedical research, mirroring the success of open-source software.
• Widespread adoption of open-source antibodies will foster greater transparency, reproducibility, and innovation.
• Support from funding agencies and active researcher participation are crucial for the success of this initiative.